Description
Composition- Sitagliptin 100 mg + Metformin 500 mg
Mode of Action- Enhances incretin response while improving insulin sensitivity and reducing hepatic glucose production for dual-pathway diabetes control.
USPs- Balanced dual therapy; useful in moderate type 2 diabetes; effective glycemic support.
Prescribing Specialties- Diabetologist, General Physician
